QTL
|
Chr.
|
Pos. (CI) a (cM)
|
Left marker
|
Right marker
|
LOD
|
PVE (%) b
|
Genotypic effect
|
---|
a1
|
a2
|
a3
|
a4
|
a5
|
a6
|
a7
|
a8
|
---|
IqHD1
|
1
|
263.71 (263.06–265.16)
|
Chr1–6,588,793
|
Chr1–5,958,935
|
9.97
|
3.54
|
2.61
|
2.47
|
1.19
|
−1.34
|
−1.37
|
−0.62
|
−1.37
|
−1.56
|
IqHD2
|
2
|
84.90 (83.15–85.75)
|
Chr2–3,433,320
|
Chr2–5,042,884
|
12.92
|
5.03
|
1.26
|
−2.19
|
0.73
|
−1.27
|
2.68
|
−1.33
|
2.18
|
−2.05
|
IqHD6.1
|
6
|
8.10 (7.75–8.45)
|
Chr6–5,681,741
|
Chr6–26,069,125
|
12.68
|
4.67
|
−1.44
|
−1.81
|
1.12
|
1.77
|
−1.64
|
−1.43
|
2.52
|
0.91
|
IqHD6.2
|
6
|
92.50 (92.15–92.75)
|
Chr6–3,305,201
|
Chr6–2,927,171
|
46.04
|
21.05
|
−0.81
|
−1.67
|
−1.21
|
−0.84
|
−2.64
|
−2.65
|
9.03
|
0.79
|
IqHD8
|
8
|
42.40 (42.35–42.55)
|
Chr8–6,181,174
|
Chr8–9,288,403
|
9.11
|
3.23
|
2.05
|
−0.41
|
1.53
|
−3.72
|
−0.82
|
− 0.11
|
−0.45
|
1.94
|
IqPH1
|
1
|
358.21 (358.06–358.26)
|
Chr1–38,503,485
|
Chr1–38,103,681
|
19.49
|
9.47
|
−2.49
|
− 2.86
|
7.78
|
−5.47
|
−4.61
|
7.18
|
3.34
|
−2.88
|
IqPH2
|
2
|
304.21 (304.16–304.76)
|
Chr2–418,968
|
Chr2–2,416,287
|
11.11
|
5.19
|
−4.67
|
1.96
|
3.66
|
−1.56
|
−2.36
|
4.85
|
0.86
|
−2.74
|
IqPH11
|
11
|
46.10 (44.65–46.95)
|
Chr11–19,718,068
|
Chr11–23,080,452
|
10.36
|
4.73
|
−3.06
|
−2.47
|
− 3.85
|
−4.11
|
2.79
|
3.99
|
2.57
|
4.15
|
- aPosition in cM and 1-LOD confidence interval (CI)
- bPercentage of phenotypic variance explained